I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Impact of veliparib, paclitaxel dosing regimen, and germlin..:
Aghajanian, Carol
;
Swisher, Elizabeth M
;
Okamoto, Aikou
...
qt3kh4b5pc. , 2022
Link:
https://escholarship.org/uc/item/3kh4b5pc
RT Journal T1
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt3kh4b5pc&Exemplar=1&LAN=DE A1 Aghajanian, Carol A1 Swisher, Elizabeth M A1 Okamoto, Aikou A1 Steffensen, Karina Dahl A1 Bookman, Michael A A1 Fleming, Gini F A1 Friedlander, Michael A1 Moore, Kathleen N A1 Tewari, Krishnansu S A1 O'Malley, David M A1 Chan, John K A1 Ratajczak, Christine A1 Hashiba, Hideyuki A1 Wu, Meijing A1 Dinh, Minh H A1 Coleman, Robert L PB eScholarship, University of California YR 2022 K1 Biomedical and Clinical Sciences K1 Oncology and Carcinogenesis K1 Ovarian Cancer K1 Clinical Research K1 Clinical Trials and Supportive Activities K1 Rare Diseases K1 Cancer K1 Patient Safety K1 6.1 Pharmaceuticals K1 Evaluation of treatments and therapeutic interventions K1 Adult K1 Aged K1 80 and over K1 Antineoplastic Combined Chemotherapy Protocols K1 Benzimidazoles K1 Carboplatin K1 Carcinoma K1 Ovarian Epithelial K1 Drug Administration Schedule K1 Female K1 Genes K1 BRCA1 K1 BRCA2 K1 Germ-Line Mutation K1 Hereditary Breast and Ovarian Cancer Syndrome K1 Humans K1 Induction Chemotherapy K1 Maintenance Chemotherapy K1 Middle Aged K1 Neoplasms K1 Cystic K1 Mucinous K1 and Serous K1 Ovarian Neoplasms K1 Paclitaxel K1 Poly(ADP-ribose) Polymerase Inhibitors K1 Progression-Free Survival K1 Young Adult K1 Veliparib K1 PARP inhibitor K1 Dose-dense paclitaxel K1 g BRCA K1 Homologous recombination de ficiency K1 Homologous recombination deficiency K1 gBRCA K1 Paediatrics and Reproductive Medicine K1 Oncology & Carcinogenesis JF qt3kh4b5pc LK http://dx.doi.org/https://escholarship.org/uc/item/3kh4b5pc DO https://escholarship.org/uc/item/3kh4b5pc SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)